Market Overview

15 Biggest Mid-Day Gainers For Tuesday

  • Avenue Therapeutics Inc (NASDAQ: ATXI) shares gained 32 percent to $7.92. Avenue Therapeutics priced its 5.5 million share IPO at $6.00 per share.
  • Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares surged 19.2 percent to $17.16. Delaware Supreme Court ruled in favor of Chicago Bridge & Iron in dispute with Westinghouse Electric, Reuters reported.
  • Strongbridge Biopharma plc (NASDAQ: SBBP) shares climbed 12.6 percent to $6.70 as the company disclosed that it has completed its enrollment target of 90 patients in the Phase 3 SONICS study evaluating RECORLEV™ for the treatment of endogenous Cushing’s syndrome.
  • Zion Oil & Gas, Inc. (NASDAQ: ZN) shares rose 12.6 percent to $3.12.
  • Handy & Harman Ltd (NASDAQ: HNH) shares jumped 11.8 percent to $31.85 after Steel Partners Holdings LP (NYSE: SPLP) agreed to acquire the remaining outstanding shares of Handy & Harman.
  • Cobalt International Energy, Inc. (NYSE: CIE) shares rose 10.7 percent to $2.68.
  • SurModics, Inc. (NASDAQ: SRDX) climbed 10.2 percent to $27.83. Aegis Capital initiated coverage on SurModics with a Buy rating.
  • CARBO Ceramics Inc. (NYSE: CRR) shares surged 7.7 percent to $6.86.
  • Amarin Corporation plc (ADR) (NASDAQ: AMRN) shares gained 6.2 percent to $3.66. Cantor Fitzgerald assumed coverage on Amarin with an Overweight rating and a price target of $10.00.
  • Sprint Corp (NYSE: S) shares rose 5.6 percent to $8.46 after Wall Street Journal reported a possible wireless partnership with Charter and Comcast.
  • NxStage Medical, Inc. (NASDAQ: NXTM) shares gained 5 percent to $24.58. Craig-Hallum initiated coverage on NxStage Medical with a Buy rating.
  • Affimed NV (NASDAQ: AFMD) shares climbed 4.7 percent to $2.25. Affimed presented preclinical data for AFM24 and AFM26 programs at the EACR-AACR-SIC 2017.
  • J C Penney Company Inc (NYSE: JCP) rose 4.7 percent to $4.89. Gordon Haskett upgraded J C Penney from Reduce to Hold.
  • Darden Restaurants, Inc. (NYSE: DRI) gained 4.6 percent to $94.21 after the company reported stronger-than-expected results for its fourth quarter.
  • Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) rose 4.4 percent to $15.75. Citigroup initiated coverage on Arena Pharmaceuticals with a Buy rating.

Related Articles (AMRN + AFMD)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Analyst Ratings Movers

Latest Ratings

UBERRBC CapitalMaintains50.0
WIXJMP SecuritiesMaintains363.0
CVIJP MorganInitiates Coverage On22.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at